Novel pathogenic variant in haploinsufficiency of A20 with severe gastrointestinal effects and fulminant hepatic failure: A pediatric case series
), encoding a negative regulator of nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB) signaling. We report two pediatric patients with a previously unreported novel pathogenic variant (p. Glu409*) in the zinc finger (ZnF) 1 domain, exhibiting markedly divergent phenotypes. Case 1 presented with very-early-onset inflammatory bowel disease (VEO-IBD) and autoimmune thyroiditis, requiring aggressive infliximab dose escalation. Case 2 developed fulminant hepatic failure requiring liver transplantation, followed by post-transplant complications including refractory rejection, recurrent infections, and post-transplant lymphoproliferative disorder. This represents the first known case of HA20 in solid organ transplantation. These cases underscore the importance of early genetic diagnosis in unexplained pediatric inflammatory disease and transplant rejection, as HA20 recognition may alter immunosuppressive strategies and guide therapies including cytokine blockade or Janus kinase (JAK) inhibition.
Authors
- Kwun Wah Wen (ORCID: https://orcid.org/0000-0002-8251-902X)
- Joshua T. Byers (ORCID: https://orcid.org/0000-0001-5064-4603)
- Alice Y. K. Chan (ORCID: https://orcid.org/0000-0003-1466-7044)
- Sabina A. Ali (ORCID: https://orcid.org/0000-0002-5887-5454)
- Katherine Cheng (ORCID: https://orcid.org/0000-0002-7283-590X)
- Amanda Blake (ORCID: https://orcid.org/0009-0008-0072-8970)
Institutions
- University of California, San Francisco (US)
- University of California San Francisco Medical Center (US)
Publication Details
- Journal
- JPGN Reports
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1002/jpr3.70309
- Primary Topic
- Immunodeficiency and Autoimmune Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Howard Hughes Medical Institute
- Wellcome Trust
- National Institutes of Health